Related Experiment Video

Updated: Mar 31, 2026

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates
09:47

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates

Published on: May 10, 2022

3.3K

TRIB2 and the ubiquitin proteasome system in cancer

Mara Salomè1, Joana Campos1, Karen Keeshan2

  • 1Paul O'Gorman Leukaemia Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, G12 0ZD, Scotland.

Biochemical Society Transactions
|October 31, 2015
PubMed

Insights

Tribbles homolog 2 (TRIB2) proteins degrade target proteins via the ubiquitin proteasome system (UPS). This review details TRIB2

Area of Science:

  • Molecular biology
  • Cancer research
  • Protein degradation

Background:

  • Tribbles (TRIB) proteins are pseudokinases regulating protein degradation.
  • The ubiquitin proteasome system (UPS) is a key cellular pathway for protein turnover.
  • Tribbles homolog 2 (TRIB2) is implicated in various cancers, including leukemia, lung, and liver cancer.

Purpose of the Study:

  • To review the molecular interactions between TRIB2 and UPS factors.
  • To elucidate the role of these interactions in cancer development.
  • To provide a comprehensive understanding of TRIB2's function in oncogenesis.

Main Methods:

  • Literature review of studies on TRIB2 and UPS interactions.
  • Analysis of TRIB2's role in cancer pathogenesis.
  • Examination of TRIB2's substrate specificity, including CCAAT enhancer binding protein α (C/EBPα).

Main Results:

  • TRIB2 interacts with various UPS components, influencing substrate degradation.
  • These interactions are context-dependent and have differential effects on cancer progression.
  • CCAAT enhancer binding protein α (C/EBPα) is a well-characterized substrate degraded by TRIB2.

Conclusions:

  • Understanding TRIB2-UPS interactions is crucial for cancer biology.
  • TRIB2's role in cancer is mediated through its modulation of protein degradation pathways.
  • Targeting TRIB2-UPS interactions may offer novel therapeutic strategies for cancer treatment.
Keywords:
TRIB2cancerleukaemiaubiquitin proteasome

More Related Videos

Assaying Proteasomal Degradation in a Cell-free System in Plants07:43

Assaying Proteasomal Degradation in a Cell-free System in Plants

Published on: March 26, 2014

15.2K
Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

1.6K

Related Concept Videos

The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
2.0K
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.5K
The Proteasome02:18

The Proteasome

5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
9.2K